rs1060501125

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_003924.4(PHOX2B):​c.779C>T​(p.Ala260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A260P) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PHOX2B
NM_003924.4 missense

Scores

2
2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.633

Publications

0 publications found
Variant links:
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]
PHOX2B Gene-Disease associations (from GenCC):
  • central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Haddad syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • neuroblastoma, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
  • congenital central hypoventilation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23537415).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003924.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHOX2B
NM_003924.4
MANE Select
c.779C>Tp.Ala260Val
missense
Exon 3 of 3NP_003915.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHOX2B
ENST00000226382.4
TSL:1 MANE Select
c.779C>Tp.Ala260Val
missense
Exon 3 of 3ENSP00000226382.2
PHOX2B
ENST00000510424.2
TSL:3
n.*60C>T
downstream_gene
N/A

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1142910
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
552554
African (AFR)
AF:
0.00
AC:
0
AN:
23722
American (AMR)
AF:
0.00
AC:
0
AN:
10920
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16798
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25452
South Asian (SAS)
AF:
0.00
AC:
0
AN:
30236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3338
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
955556
Other (OTH)
AF:
0.00
AC:
0
AN:
45348
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Haddad syndrome (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.020
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.18
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.24
T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.63
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-0.10
N
REVEL
Benign
0.26
Sift
Benign
0.088
T
Sift4G
Benign
0.35
T
Polyphen
0.0
B
Vest4
0.33
MutPred
0.41
Gain of catalytic residue at A260 (P = 0.0662)
MVP
0.88
MPC
1.1
ClinPred
0.043
T
GERP RS
1.0
Varity_R
0.065
gMVP
0.56
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060501125; hg19: chr4-41747990; API